University of Colorado Anschutz Medical Campus

CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study (2023) Kang EY, Weir A, Meagher NS, Farrington K, Nelson GS, Ghatage P, Lee CH, et al. Journal article Outcomes of rescue procedures in the management of locally recurrent ampullary tumors: A Pancreas 2000/EPC study (2023) Karam E, Hollenbach M, Ali EA, Auriemma F, Gulla A, Heise C, Regner S, et al. Journal article Image-based profiling: a powerful and challenging new data type (2022) Way GP, Spitzer H, Burnham P, Raj A, Theis F, Singh S, Carpenter AE Conference contribution Genetic loci and prioritization of genes for kidney function decline derived from a meta-analysis of 62 longitudinal genome-wide association studies (2022) Gorski M, Rasheed H, Teumer A, Thomas LF, Graham SE, Sveinbjornsson G, Winkler TW, et al. Journal article Arthritis flares mediated by tissue-resident memory T cells in the joint (2021) Chang MH, Levescot A, Nelson-Maney N, Blaustein RB, Winden KD, Morris A, Wactor A, et al. Journal article Murine esophagus expresses glial‐derived central nervous system antigens (2021) Kapitza C, Chunder R, Scheller A, Given KS, Macklin WB, Enders M, Kürten S, et al. Journal article Reducing Cardiac Radiation Dose From Breast Cancer Radiation Therapy With Breath Hold Training and Cognitive Behavioral Therapy (2020) Mayr NA, Borm KJ, Kalet AM, Wootton LS, Chadderdon AL, Combs SE, Wang W, et al. Journal article, Review article Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial (2020) Migden MR, Khushalani NI, Chang ALS, Lewis KD, Schmults CD, Hernandez-Aya L, Meier F, et al. Journal article New insights into the clinical and molecular spectrum of the novel CYFIP2-related neurodevelopmental disorder and impairment of the WRC-mediated actin dynamics (2020) Begemann A, Sticht H, Begtrup A, Vitobello A, Faivre L, Banka S, Alhaddad B, et al. Journal article Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results (2020) Fleischer DM, Shreffler WG, Campbell DE, Green TD, Anvari S, Assa'ad A, Bégin P, et al. Journal article